Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Clemensia Nakabiito

Biographic Data

ID7728184
NAMEClemensia Nakabiito
GIVEN NAMESClemensia
FAMILY NAMENakabiito
SIGNATURENAKABIITO C
AFFILIATIONSMUJHU Research Collaboration
VERIFIEDNo
TOTAL WORKS7
TOTAL CITATIONS0
WORKS AS AUTHOR7
WORKS AS EDITOR0
FIRST PUBLICATION YEAR1999
LATEST PUBLICATION YEAR2022
H-INDEX0
  • Couples’ Preferences for “2 in 1” Multipurpose Prevention Technologies to Prevent Both HIV and Pregnancy

    Open Access•Alexandra M Minnis, Juliane Etima et al.•ARTICLE•AIDS and Behavior•2022

  • Couples’ decision making regarding the use of multipurpose prevention technology (MPT) for pregnancy and HIV prevention

    Open Access•Marie C D Stoner, Erica N Browne et al.•ARTICLE•AIDS and Behavior•2022

  • Correlates of Dapivirine Vaginal Ring Acceptance among Women Participating in an Open Label Extension Trial

    Open Access•Brenda Gati Mirembe, Maria Valdez Cabrera et al.•ARTICLE•AIDS and Behavior•2022

  • Use of a Vaginal Ring Containing Dapivirine for HIV-1 Prevention in Women

    Jared M Baeten, Thesla Palanee‐phillip et al.•ARTICLE•New England Journal of Medicine•2016

    BACKGROUND: Antiretroviral medications that are used as prophylaxis can prevent acquisition of human immunodeficiency virus type 1 (HIV-1) infection. However, in clinical trials among African women, the incidence of HIV-1 infection was not reduced, probably because of low adherence. Longer-acting methods of drug delivery, such as vaginal rings, may simplify use of antiretroviral medications and provide HIV-1 protection. METHODS: We conducted a ph…

  • Tenofovir-Based Preexposure Prophylaxis for HIV Infection among African Women

    Jeanne Marrazzo, Jeanne M Marrazzo et al.•ARTICLE•New England Journal of Medicine•2015

    BACKGROUND: Reproductive-age women need effective interventions to prevent the acquisition of human immunodeficiency virus type 1 (HIV-1) infection. METHODS: We conducted a randomized, placebo-controlled trial to assess daily treatment with oral tenofovir disoproxil fumarate (TDF), oral tenofovir-emtricitabine (TDF-FTC), or 1% tenofovir (TFV) vaginal gel as preexposure prophylaxis against HIV-1 infection in women in South Africa, Uganda, and Zimb…

  • Adherence and Acceptability in MTN 001

    Open Access•Alexandra M Minnis, Sharavi Gandham et al.•ARTICLE•AIDS and Behavior•2012

  • Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda

    Open Access•Laura Guay, Laura A Guay et al.•ARTICLE•The Lancet•1999

No prominent works on this page.

  • Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda

    Open Access•Laura Guay, Laura A Guay et al.•ARTICLE•The Lancet•1999

  • Adherence and Acceptability in MTN 001

    Open Access•Alexandra M Minnis, Sharavi Gandham et al.•ARTICLE•AIDS and Behavior•2012

  • Tenofovir-Based Preexposure Prophylaxis for HIV Infection among African Women

    Jeanne Marrazzo, Jeanne M Marrazzo et al.•ARTICLE•New England Journal of Medicine•2015

    BACKGROUND: Reproductive-age women need effective interventions to prevent the acquisition of human immunodeficiency virus type 1 (HIV-1) infection. METHODS: We conducted a randomized, placebo-controlled trial to assess daily treatment with oral tenofovir disoproxil fumarate (TDF), oral tenofovir-emtricitabine (TDF-FTC), or 1% tenofovir (TFV) vaginal gel as preexposure prophylaxis against HIV-1 infection in women in South Africa, Uganda, and Zimb…

  • Use of a Vaginal Ring Containing Dapivirine for HIV-1 Prevention in Women

    Jared M Baeten, Thesla Palanee‐phillip et al.•ARTICLE•New England Journal of Medicine•2016

    BACKGROUND: Antiretroviral medications that are used as prophylaxis can prevent acquisition of human immunodeficiency virus type 1 (HIV-1) infection. However, in clinical trials among African women, the incidence of HIV-1 infection was not reduced, probably because of low adherence. Longer-acting methods of drug delivery, such as vaginal rings, may simplify use of antiretroviral medications and provide HIV-1 protection. METHODS: We conducted a ph…

  • Couples’ Preferences for “2 in 1” Multipurpose Prevention Technologies to Prevent Both HIV and Pregnancy

    Open Access•Alexandra M Minnis, Juliane Etima et al.•ARTICLE•AIDS and Behavior•2022

  • Couples’ decision making regarding the use of multipurpose prevention technology (MPT) for pregnancy and HIV prevention

    Open Access•Marie C D Stoner, Erica N Browne et al.•ARTICLE•AIDS and Behavior•2022

  • Correlates of Dapivirine Vaginal Ring Acceptance among Women Participating in an Open Label Extension Trial

    Open Access•Brenda Gati Mirembe, Maria Valdez Cabrera et al.•ARTICLE•AIDS and Behavior•2022

HIV/AIDS Research and Interventions (7 works) · Medicine (7 works) · Environmental health (4 works) · Population (4 works) · Adolescent Sexual and Reproductive Health (3 works) · Family medicine (3 works) · Family planning (3 works) · Gynecology (3 works) · Health psychology (3 works) · HIV Research and Treatment (3 works)

Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae